Cargando…
Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells
Worldwide, the number of cancer-related deaths continues to increase due to the ability of cancer cells to become chemotherapy-resistant and metastasize. For women with ovarian cancer, a staggering 70% will become resistant to the front-line therapy, cisplatin. Although many mechanisms of cisplatin...
Autores principales: | Rabelo-Fernández, Robert J., Santiago-Sánchez, Ginette S., Sharma, Rohit K., Roche-Lima, Abiel, Carrion, Kelvin Carrasquillo, Rivera, Ricardo A. Noriega, Quiñones-Díaz, Blanca I., Rajasekaran, Swetha, Siddiqui, Jalal, Miles, Wayne, Rivera, Yasmarie Santana, Valiyeva, Fatima, Vivas-Mejia, Pablo E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745614/ https://www.ncbi.nlm.nih.gov/pubmed/35008958 http://dx.doi.org/10.3390/ijms23010535 |
Ejemplares similares
-
Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells
por: Rabelo-Fernández, Robert J., et al.
Publicado: (2022) -
Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
por: Grafals-Ruiz, Nilmary, et al.
Publicado: (2020) -
Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer
por: Noriega-Rivera, Ricardo, et al.
Publicado: (2022) -
Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2021) -
Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)